Randall Jordan Ellis

Randall Jordan Ellis

Auto-generated profile, based on publicly available information

Randall Jordan Ellis

Department of Biomedical Informatics, Harvard Medical School

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2017 in Science
Verified
Journal Article
Closed access
PDF file
JGJuan L. Gomez
Juan L. Gomez
JBJordi Bonaventura
Jordi Bonaventura
WLWojciech Lesniak
Wojciech Lesniak
WMWilliam B. Mathews
William B. Mathews
PSPolina Sysa-Shah
Polina Sysa-Shah
MMMichael Michaelides
Michael Michaelides
DREADD not the designer compound: Designer receptors exclusively activated by designer drugs (DREADDs) constitute a powerful chemogenetic strategy that can modulate nerve cell activity in freely moving animal preparations. Gomez et al. used radioligand receptor occupancy measurements and in vivo positron emission tomography to show that DREADDs expressed in the brain are not activated by the designer compound CNO (clozapine N -oxide). Instead, they are activated by the CNO metabolite clozapine, a drug with multiple endogenous targets. This may have important implications for the interpretation of results obtained with this popular technology. Science , this issue p. 503

29 January 2019 in BioData Mining
Verified
Journal Article
Open access
PDF file
RERandall J. Ellis
Randall J. Ellis
ZWZichen Wang
Zichen Wang
NGNicholas Genes
Nicholas Genes
AMAvi Ma’ayan
Avi Ma’ayan
The opioid epidemic in the United States is averaging over 100 deaths per day due to overdose. The effectiveness of opioids as pain treatments, and the drug-seeking behavior of opioid addicts, leads physicians in the United States to issue over 200 million opioid prescriptions every year. To better understand the biomedical profile of opioid-dependent patients, we analyzed information from electronic health records (EHR) including lab tests, vital signs, medical procedures, prescriptions, and other data from millions of patients to predict opioid substance dependence. We trained a machine learning model to classify patients by likelihood of having a diagnosis of substance dependence using EHR data from patients diagnosed with substance dependence, along with control patients with no history of substance-related conditions, matched by age, gender, and status of HIV, hepatitis C, and sickle cell disease. The top machine learning classifier using all features achieved a mean area under the receiver operating characteristic (AUROC) curve of ~ 92%, and analysis of the model uncovered associations between basic clinical factors and substance dependence. Additionally, diagnoses, prescriptions, and procedures prior to the diagnoses of substance dependence were analyzed to elucidate the clinical profile of substance-dependent patients, relative to controls. The predictive model may hold utility for identifying patients at risk of developing dependence, risk of overdose, and opioid-seeking patients that report other symptoms in their visits to the emergency room.

26 June 2022 in Intelligence-Based Medicine
Verified
Journal Article
Open access
RERandall J. Ellis
Randall J. Ellis
RSRyan M. Sander
Ryan M. Sander
ALAlfonso Limon
Alfonso Limon

14 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
GEGabor Egervari
Gabor Egervari
DADiana Akpoyibo
Diana Akpoyibo
HRHabeebur Rahman
Habeebur Rahman
JFJohn F. Fullard
John F. Fullard
JCJames E. Callens
James E. Callens
YHYasmin L. Hurd
Yasmin L. Hurd
The current opioid epidemic necessitates a better understanding of human addiction neurobiology to develop efficacious treatment approaches. Here, we perform genome-wide assessment of chromatin accessibility of the human striatum in heroin users and matched controls. Our study reveals distinct neuronal and non-neuronal epigenetic signatures, and identifies a locus in the proximity of the gene encoding tyrosine kinase FYN as the most affected region in neurons. FYN expression, kinase activity and the phosphorylation of its target Tau are increased by heroin use in the post-mortem human striatum, as well as in rats trained to self-administer heroin and primary striatal neurons treated with chronic morphine in vitro. Pharmacological or genetic manipulation of FYN activity significantly attenuates heroin self-administration and responding for drug-paired cues in rodents. Our findings suggest that striatal FYN is an important driver of heroin-related neurodegenerative-like pathology and drug-taking behavior, making FYN a promising therapeutic target for heroin use disorder.

2 August 2022 in eneuro
Verified
Journal Article
Open access
PDF file
RERandall J. Ellis
Randall J. Ellis
Replicability, the degree to which a previous scientific finding can be repeated in a distinct set of data, has been considered an integral component of institutionalized scientific practice since its inception several hundred years ago. In the past decade, large-scale replication studies have demonstrated that replicability is far from favorable, across multiple scientific fields. Here, I evaluate this literature and describe contributing factors including the prevalence of questionable research practices (QRPs), misunderstanding ofp-values, and low statistical power. I subsequently discuss how these issues manifest specifically in preclinical neuroscience research. I conclude that these problems are multifaceted and difficult to solve, relying on the actions of early and late career researchers, funding sources, academic publishers, and others. I assert that any viable solution to the problem of substandard replicability must include changing academic incentives, with adoption of registered reports being the most immediately impactful and pragmatic strategy. For animal research in particular, comprehensive reporting guidelines that document potential sources of sensitivity for experimental outcomes is an essential addition.

28 June 2018 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
MMMichael Michaelides
Michael Michaelides
MMMichael L Miller
Michael L Miller
GEGabor Egervari
Gabor Egervari
SPStefany D. Primeaux
Stefany D. Primeaux
JGJuan L. Gomez
Juan L. Gomez
YHYasmin L. Hurd
Yasmin L. Hurd